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Genetic modification of human
mesenchymal stem cells helps to reduce
adiposity and improve glucose tolerance in
an obese diabetic mouse model
Sabyasachi Sen1*, Cleyton C. Domingues1, Carol Rouphael1, Cyril Chou2, Chul Kim2 and Nagendra Yadava2
Abstract
Introduction: Human mesenchymal stem cells (MSCs) are multipotent cells that can differentiate into fat, muscle,
bone and cartilage cells. Exposure of subcutaneous abdominal adipose tissue derived AD-MSCs to high glucose
(HG) leads to superoxide accumulation and up-regulation of inflammatory molecules. Our aim was to inquire how
HG exposure affects MSCs differentiation and whether the mechanism is reversible.
Methods: We exposed human adipose tissue derived MSCs to HG (25 mM) and compared it to normal glucose
(NG, 5.5 mM) exposed cells at 7, 10 and 14 days. We examined mitochondrial superoxide accumulation (Mitosox-Red),
cellular oxygen consumption rate (OCR, Seahorse) and gene expression.
Results: HG increased reactive superoxide (ROS) accumulation noted by day 7 both in cytosol and mitochondria. The
OCR between the NG and HG exposed groups however did not change until 10 days at which point OCR of HG
exposed cells were reduced significantly. We noted that HG exposure upregulated mRNA expression of adipogenic
(PPARG, FABP-4, CREBP alpha and beta), inflammatory (IL-6 and TNF alpha) and antioxidant (SOD2 and Catalase) genes.
Next, we used AdSOD2 to upregulate SOD2 prior to HG exposure and thereby noted reduction in superoxide
generation. SOD2 upregulation helped reduce mRNA over-expression of PPARG, FABP-4, IL-6 and TNFα. In a series
of separate experiments, we delivered the eGFP and SOD2 upregulated MSCs (5 days post ex-vivo transduction)
and saline intra-peritoneally (IP) to obese diabetic (db/db) mice. We confirmed homing-in of eGFP labeled MSCs,
delivered IP, to different inflamed fat pockets, particularly omental fat. Mice receiving SOD2-MSCs showed
progressive reduction in body weight and improved glucose tolerance (GTT) at 4 weeks, post MSCs
transplantation compared to the GFP-MSC group (control).
Conclusions: High glucose evokes superoxide generation, OCR reduction and adipogenic differentiation.
Mitochondrial superoxide dismutase upregulation quenches excess superoxide and reduces adipocyte inflammation.
Delivery of superoxide dismutase (SOD2) using MSCs as a gene delivery vehicle reduces inflammation and improves
glucose tolerance in vivo. Suppression of superoxide production and adipocyte inflammation using mitochondrial
superoxide dismutase may be a novel and safe therapeutic tool to combat hyperglycemia mediated effects.
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Introduction
Obesity and diabetes are increasing at alarming rates
throughout the world leading to an increase in co-
morbidities [1]. Dyslipidemia and insulin resistance pre-
dispose to type 2 diabetes and metabolic syndrome [2–4].
In this scenario, study of the effects of hyperglycemia and
metabolic syndrome on adult stem cells or progenitors to
mature endothelial cells, fat/muscle/cartilage cells is im-
portant. In this article we have focused on studying the ef-
fects of high glucose on long term structural stem cells,
such as mesenchymal stem cells (MSCs). MSCs are multi-
potent stem cells that are precursors of osteoblasts, chon-
droblasts, and preadipocytes. They can differentiate into
bone, cartilage, and adipocytes in the presence of a par-
ticular environment or cell culture condition [5]. They can
be obtained from multiple sources, such as subcutaneous
fat and bone marrow.
Increased oxidative stress and inflammation have been
observed in adipose tissue pockets in hyperglycemia, dia-
betes, and obesity models [6–8]. It has been noted that
human MSCs derived from muscle source when cul-
tured in high glucose (25 mM glucose) and compared to
normal glucose (5 mM glucose) promote accumulation
of reactive oxygen species (ROS) [7–15]. However, a sys-
tematic and time dependent study of glucose effects on
this important cell type is lacking.
In this study, we report the association between ROS
and hyperglycemia, and the effect on adipogenic genes
and cellular inflammation in human mesenchymal stem
cells (MSCs). Most of our experiments used primary adi-
pose tissue derived MSCs (ADMSC) and we also con-
firmed some of our cell based experiments using
primary human bone marrow derived MSCs(BMMSCs).
The biological paradox of oxygen and obesity
ROS are produced during normal cellular metabolism
from incomplete reduction of oxygen. They have been
shown to be cytotoxic, but also function as signaling
molecules [7, 8, 10]. Therefore, understanding the mech-
anisms and pathways that regulate ROS homeostasis is
crucial for the integrity of living organisms. This appar-
ent paradox of beneficial vs cytotoxic effects of ROS can
be balanced by well-developed enzymatic and non-
enzymatic antioxidant systems to minimize the cellular
damage and triggering of unwanted differentiation path-
ways caused by excessive ROS [11–13]. When ROS gen-
eration is increased to an extent that overwhelms the
intracellular antioxidant defense systems, it leads to oxi-
dative stress. This causes cellular and tissue damage by
readily oxidizing critical macromolecules including pro-
teins, lipids and nucleic acids, thereby contributing to
the pathogenesis of many degenerative and/or chronic
metabolic diseases. Recent literature suggests that in-
creased ROS production from adipose tissue in obese
subjects leads to systemic oxidative stress, primarily due
to reduced antioxidant capacity, contributing to the de-
velopment of obesity-linked diseases [14–17]. In simple
terms, the antioxidant process progresses as follows:
nascent oxygen [O] + H2O ——via Superoxide Dismutase
(either SOD1 or SOD2) converts to H2O2. H2O2 is subse-
quently broken down to H2O and O2 with the help of en-
zymes, i.e., catalase and glutathione peroxidase (GPX).
MnSOD or SOD2 is found in mitochondria and Cu-Zn
SOD(SOD1), catalase and GPX are cytosolic [17].
Methods
Cell based assays and mitochondrial function assays
Cell culture and adipogenic differentiation
ADMSCs and BMMSCs were obtained from Lonza
Walkersville, MD, USA. ADMSCs were initially cultured
in DMEM normal glucose (NG, 5.5 mM; 1gm/L, Life
Technologies Carlsbad, CA) containing 10 % fetal bovine
serum and 1 % penicillin/streptomycin. Alternatively,
cells were also cultured in the presence of DMEM high
glucose (HG, 25 mM, 4.5gms/L, Life Technologies) up
to 14 days. Culture medium was changed every 48 to
72 h until the cells were harvested. To induce adipo-
genic differentiation the cells were cultured in cycles of
three days by alternating between adipogenic (NG or HG
supplemented with 0.5 μM dexamethasone, 0.5 μM isobu-
tylmethylxanthine, and 50 μM indomethacin) and main-
tenance medium (NG or HG). Fat droplets accumulation
was assessed by Oil Red O staining [7, 8] Fig. 1. Culture
conditions using NG or HG media were also referred to
as normoglycemic or hyperglycemic respectively.
For BMMSCs we used MSCGM media from Lonza
and adjusted glucose content to make it 25 mM for high
glucose experiments.
RNA extraction, cDNA synthesis and gene expression
Gene expression was assessed via reverse transcriptase
PCR (RT-PCR). Total mRNA from adiposetissue-derived
MSCs was extracted and purified using the RNeasy Mini
Kit (Qiagen Germantown, MD). RNA conversion into
cDNA was performed in T100 Thermal Cycler (Bio-Rad
Hercules, CA) using the High Capacity cDNA Reverse
Transcription Kit (Applied Biosystems Foster City, CA).
The genes of interest were analyzed using CFX96 Real-
Time System (Bio-Rad) in a 25 μL qPCR TaqMan reac-
tion (Applied Biosystems). The expression of individual
genes was normalized to either 18S and/or GAPDH and
analyzed as cycle threshold (Ct) difference. The target
gene expression results are reported as ΔΔCt values. Hu-
man genes tested in NG and HG, Figs. 2 and 3 were: IL-
6 (interleukin 6), TNFα (tumor necrosis factor- alpha),
SOD1, 2 and 3 (superoxide dismutases), CAT (catalase),
GPX-3 (glutathione peroxidase-3), CEBPa (cholesterol
ester binding protein alpha), CEBPb (cholesterol ester
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binding protein beta), FABP4 (fatty acid binding protein-
4), PLIN (perilipin), PPARG (peroxisome proliferator-
activated receptor gamma), PPARGC1A (peroxisome
proliferator-activated receptor gamma, coactivator 1
Alpha), SREBP1 (sterol regulatory element-binding
protein 1), SREBP2 (sterol regulatory element-binding
protein 2), LEP (leptin), ALPL (alkaline phosphatase)
and BGLAP (osteocalcin) NDUFA1 (NADH:ubiquinone
oxidoreductase subunit A1) and SDHB (Succinate
Dehydrogenase Complex, Subunit B).
Complex I assay by BN-PAGE
Mitochondria from MSCs grown under NG or HG con-
ditions were isolated by differential centrifugation and
solubilized with dodecyl-β-D-maltoside (Sigma St Loius,
MO) in 50 mM imidazole-HCl (pH 7.0) containing
5 mM 6-aminohexanoic acid and 10 % glycerol at 2:1
detergent: protein ratio. Oxidative phosphorylation
(OXPHOS) complexes were separated by blue native-
polyacrylamide gel electrophoresis (BN-PAGE) and
detected using specific antibodies by Western blotting
as described earlier [18, 19]. Respectively, Complexes I
and II were detected using specific antibodies against
NDUFS3 and SDHB (MitoSciences-Abcam Cambridge,
MA) (Fig. 4a and 4b).
Oxygen consumption rate (OCR) determination
OCR was determined using Extracellular Flux Analyzers
XFp and XF24-3 (Seahorse Biosciences Massachusetts,
USA) as described [20, 21].
For assays with XFp (in both Figs. 5 and 13) approxi-
mately 2 × 104 per well were seeded in V7-PS mini-plates
and allowed to grow in a CO2 incubator at 37 °C. After
24 hours cells were washed twice with assay medium
Fig. 1 MSCs in normal and high glucose: DMEM-normal glucose on the left and in DMEM- high glucose on the right. The MSCs in high glucose
show multiple fat droplet accumulation, intra-cellularly, stained with oil red O stain. Magnification: 40×. MSCs mesenchymal stem cells, DMEM
Dulbecco’s modified Eagle’s medium
Fig. 2 Effect of high glucose on MSC gene expression at Day 7 and 14. MSCs were exposed to normal and high glucose for 7 (black bars) and 14
(gray bars) days. Inflammatory, antioxidant, and adipogenic markers mRNA expression was analyzed by real time PCR. mRNA expression results of
HG vs NG exposed cells were compared at the two different time points. Data are expressed as mean of three independents experiments ± SEM
(paired t-test, *P < 0.05). MSC mesenchymal stem cell, PCR polymerase chain reaction, HG high glucose, NG normal glucose
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(non-buffered XF Base Medium minimum DMEM;
Seahorse Bioscience, Catalog: 102353–100), pH 7.4,
containing 5.5 mM glucose, 1 mM pyruvate, and 2 mM
glutamine and kept in the same medium. After that,
cells were incubated in a CO2-free incubator at 37 °C
for 30–60 min prior to the assay.
We also used SeaHorse XF24, (Fig. 6) the MSCs were
treated for seven days in NG and HG in their usual cul-
ture media. On the eighth day, 70000 of either normal
or high glucose treated cells were seeded on the poly-
ethyleneimine (PEI) coated XF24 well in appropriate
media. The plate was placed in a hood without light for
30 min and was subjected to centrifugation for 10 min
at 2,000 rpm at room temperature. The plate was incu-
bated in a CO2-incubator for three hours. The plate
medium was discarded and then the plate was washed
with Ca2+-free low K+ buffer (LKB) containing 3.5 mM
KCl, 120 mM NaCl, 0.4 mM KH2PO4, 1.2 mM Na2SO4,
2 mM MgCl2, 1mM EGTA (ethyleneglycol-tetra-acetic
acid), 20 mM Na-N-Tris-(hydroxymethyl)-methyl-2-
amino-ethanesulfonic acid (TES, pH7.4) and 0.4 %
fat-free bovine serum albumin (BSA) unless otherwise
noted. Respiration media were supplemented with glu-
cose. Media was prepared and programs used for meas-
urement as described before [20, 21]. The respiration of
cells was measured with XF24 analyzer. The assay used
1 nM of rPFO (plasma membrane permeabilizer),
10 mM of glutamate, malate, and succinate, and 2 μM of
FCCP. Before rPFO injection, two min mixing, two min
waiting, and three min measuring and after rPFO injec-
tion, 30 sec mixing,1 min 30 sec waiting, and three min
measuring cycles were used.
Oxidative stress detection
Human adipose-derived MSCs (Lonza) were exposed to
high glucose media (DMEM, 25 mM glucose) for a total
of 14 days. At each of days 1, 3, 7, 10, and 14, cells were
analyzed for superoxide accumulation inside the mito-
chondria using MitoSox red dye (Life Technologies),
which is oxidized by ROS specifically inside the mito-
chondria. MitoSox was dissolved in DMSO to prepare a
5 mM stock solution. Stock solution was then dissolved
in HBSS/Ca/Mg buffer to obtain a 5 μM working solu-
tion. Cells were cultured on a 24-well plate (25,000cells/
well) Fig. 7. Wells were stained at each of days 1, 3, 7, 10
and 14 with 5 μM MitoSox solution and fluorescence
was measured at 530/590 nm by a plate reader, Fig. 8.
hMSCs cultured in HG media were stained again with
MitoSox and then observed under the microscope at
each of days 2 and 7 to check for fluorescence. The same
experiment was repeated using Mitotracker Green FM
(Life Technologies) dye instead of MitoSox and fluores-
cence was checked under the microscope at day 7 to as-
sess mitochondrial mass.
For the Mitotraker experiment Fig. 9, we plated
25,000cells/chamber on a two chamber slide. Two cham-
bers had cells cultured in NG media and two chambers had
cells cultured in HG media. At day 7, cells were incubated
in Mitotracker working solution (200nM) for 30 minutes,
washed with PBS and observed under the microscope using
the red filter (Ex:490/Em: 516 nm) for fluorescence.
In Fig. 10, MitoSox experiment was repeated at day
14 with NG and HG exposed cells along with SOD2
upregulated cells, to note if effects of HG can be
aborgated.
Cell Based Assays post superoxide dismutase (SOD) gene
upregulation
Figure 11 shows RT-PCR of adipogenic and pro-inflamma-
tory genes pre and post SOD2 over-expression in HG.
SOD2 upregulation reduces high expression of these genes
in HG. Figure 12 shows SOD activity assay (Xanthine
Oxidase Assay) in Ad Null (control), AdSOD1 and
AdSOD2 upregulated ADMSCs, detailed below. Figure 13
shows OCR tracings using Seahorse XFp machine, of
ADMSCs, in NG and HG post GFP (control), SOD1 and
SOD2 upregulation at day 10.
Xanthine oxidase fluorometric assay
We used a Superoxide Dismutase Assay Kit from Sigma
Aldrich (#19160) to detect xanthine oxidase and quantify
superoxide dismutase activity intracellularly. We tested
AdSOD1, AdSOD2, and AdNull (all constructs obtained
from Vector Biolabs Malvern, PA, USA) transduced cells
and measured intra-cellular SOD activity. In this assay
superoxide anions (O2
−) are generated by a xanthine/
xanthine oxidase (XOD) system, and then detected with
a chromagen solution. However, in the presence of SOD,
these superoxide anion concentrations are reduced,
yielding less colorimetric signal (Fig. 12).
Fig. 3 mRNA gene expression of Complex I- NDUFA1 (subunit of
Complex I) of NG and HG cultured ADMSCs at day 14. NDUFA1
mRNA expression is statistically significantly lower in HG exposed
cells NG normal glucose, HG high glucose, ADMSCs adipose tissue
derived mesenchymal stem cells
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Animal glucose tolerance tests and body composition
assessment
Animals used for this experiment were db/db leptin re-
sistant obese diabetic mice obtained from Jackson Labs,
Bar Harbor, ME, USA (Jackson Lab, Cat # 642). All ani-
mals prior to intraperitoneal (IP) MSC delivery had tail
blood glucose levels above 250 mg %, tested by one-
touch ultra glucometer.
Glucose tolerance test: All mice used were fasted for
24 hours prior to testing. Glucose solution was synthe-
sized using dextrose solid crystals from Sigma Aldrich
(cat # D9434) with a general working solution of 0.5 g
diluted in 1 mL of normal sterile saline from Hospira Lake
Forest, IL (cat # 488810) and subsequent sterilization via a
0.2 μm pore filter into a vacutainer tube for intraperito-
neal injection.
Intraperitoneal injections were performed by standard
animal care technique. Mice were lifted by the scruff of
their backs and dextrose solution was injected into the
lower left intraperitoneal region using a 1 cc syringe and
25 gauge 5/8” needle. Dextrose delivery was calculated
at a dose of 2 g per 1 kg body weight. Blood glucose
of mice was measured using an Abbott Free-Style
Lite (detection range 20-500 mg/dL) by tail tip vein
needle puncture. Glucose measurements were made
in increments of 0, 15, 30, 45, 60, 90, and 120 minutes,
with time 0 being a glucose measurement recorded prior
to intraperitoneal injection. Body composition (in grams –
Fig. 4 a Adipose tissue derived MSC (ADMSCs) cells in high glucose (HG) show mitochondrial Complex 1 (NDUFS3) dysfunction compared to
normal glucose (NG). Complex 2 used as a loading control. A: high glucose exposed, B: normal glucose exposed, C: cultured in HG media
following SOD2 upregulation, D: cultured in NG media following SOD2 upregulation. On comparing Panel A (HG, no SOD2) and panel C (HG with
SOD2) we demonstrate that SOD2 up-regulation prior to HG exposure rescues NDUFS3 band. b Bone marrow derived MSC cells in HG show
mitochondrial Complex 1 (NDUFS3) dysfunction compared to NG. Complex 2 used as a loading control. A: High glucose exposed, B: Normal glucose
exposed, C: cultured in HG media following SOD2 upregulation, D: cultured in NG media following SOD2 upregulation. On comparing Panel A (HG, no
SOD2) and panel C (HG with SOD2) we demonstrate that SOD2 up-regulation prior to HG exposure rescues NDUFS3 band. SOD2 superoxide dismutase
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fat, lean mass, free water, and total water) was measured
by MRI using an EchoMRI™-100H Analyzer [22]. Due to
the nature of the hardware, all mice were alive during
measurements and not given anesthesia. No particular
preparations were made prior to, during, or after MRI
measurements. Mice were assisted into fitted breathable
and closable hollow plastic cylinders according to their
weight where the cylinder was placed into the analyzer for
MRI scanning which took place over the course of
approximately three minutes. After measurements, mice
were let out of their cylinders and assisted back to their
respective cages. [EchoMRI:http://www.echomri.com/
Body_Composition_Mice_2MHz.aspx].
The protocol was approved by Baystate Medical Center,
Springfield, MA, USA, Institutional Animal Care and Use
Committee (IACUC) and IBC Board [#134855-13
Antioxidant gene transfer using adenovirus] and all exper-
iments were conducted under approved ethical guidelines.
The protocol was also approved by IACUC and IBC,
George Washington University, Washington DC, #A-335.
Results
To determine the effect of hyperglycemia MSCs were
cultured under HG and NG media for comparison. The
levels of lipid droplets, ROS, mitochondrial function,
and expressions of selected marker genes were assessed.
Our data suggest that HG conditions increased lipid
droplet accumulation (colored red, following Oil Red O
staining) at day 14 of culture (Fig. 1).
To determine how exposure to HG affects adipogenic
differentiation of MSCs, we measured expression of selected
genes. Our data show that HG treated MSCs presented
over-expression of fat genes PPAR-Gamma, FABP-4, inflam-
matory genes TNF- alpha, and IL6 with statistical significant
upregulation of antioxidant genes, particularly SOD2
or MnSOD and catalase, at day 14 post exposure (Fig. 2).
We have also controlled for mannitol. Compared to
Fig. 2 of our manuscript there was no difference in any
genes for Day 7 and day 14 when cells exposed to NG
was compared to NG+ equivalent mannitol. No cellular
toxicity was noted at two weeks of HG exposure.
Figure 2 also demonstrates that bone marker, such as
alkaline phosphatase gene (ALPL), mRNA expression is
reduced over time in HG environment. HG high glucose.
The very high expression of SOD2 in HG treated cells
could be a defensive strategy or a strategy to increase
H2O2 production for signaling purposes. Elevated levels
of mitochondrial ROS were also observed using Mito-
SOX probe by flow cytometry at day 7. A rightward shift
in MitoSOX fluorescence in HG compared to NG is
clearly indicative of increased mitochondrial superoxide
levels (Fig. 7). Fluorescence microscopic analysis of MSCs
also showed enhanced MitoSOX staining in MSCs cul-
tured in HG (Fig. 8). A time course of MitoSOX fluores-
cence by plate-reader demonstrated peak fluorescence at
day 7 post HG treatment (Fig. 8c). Mitotraker-Green also
confirmed similar findings at day 7 post commencement
of culture validating superoxide accumulation in mito-
chondria (Fig. 9). Since impaired respiratory chain func-
tion in hyperglycemia may result in oxidative stress, we
measured relative mitochondrial function in hypergly-
cemia vs. normoglycemia, such as oxygen consumption
rate (OCR) using Seahorse Bioscience Extracellular Flux
Analyzers (XF24, XFp). The MSCs cultured in hypergly-
cemic conditions showed lower respiration rates using
XFp (Fig. 5). The negative effect of HG on MSCs respir-
ation increased with time. Figure 5 demonstrates the pro-
gressive OCR reduction over 7, 10 and 14 days after the
start of MSCs culture in the HG condition. The reduced
OCR seen in HG exposed cells could be due to reduced
Fig. 5 Comparison of MSC basal respiration in the presence of
normal glucose (NG-circles) and high glucose (HG-squares). No cell
permeabilizer was added. The results are representative and cells
were cultured during 7 (top), 10 (middle), and 14 (bottom) days. MSC
mesenchymal stem cells
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level of assembled respiratory chain Complex I (NADH-
ubiquinone oxidoreductase). This was supported by
reduced mRNA expression of NDUFA1, a Complex 1
subunit (Fig. 3), indicating possible Complex-I defi-
ciency in hMSCs in the presence of high glucose.
RTPCR of Complex II (SDHB) did not show any change
in NG vs. HG exposed MSCs. Reduced Complex I level
and function were further supported by respirometry and
BN-PAGE data (Fig. 4). We tested the effect of SOD2 over
expression using an adenoviral viral vector (AdSOD2)
from Vector BioLabs. AdSOD2 over expression prior to
HG exposure (orange line) appears to have reduced Mito-
SOX fluorescence previously seen in HG-treated cells
(Fig. 10a and 10b). To assess whether oxidative stress
could be associated with reduced respiration and Complex
I deficiency, we assessed respiration and Complex I levels
in MSCs treated with NG and HG in the presence and ab-
sence of AdSOD2. Figure 4a demonstrates lower Complex
I activity is associated with low levels of assembled Com-
plex I as revealed by BN-PAGE, in ADMSCs which were
rescued by AdSOD2. Incidentally, the same finding is also
noted in BMMSCs (Fig. 4b). The recovery of Complex I
Fig. 6 a and b Bone marrow derived MSC showing oxygen consumption rate (OCR) in percentage in normal glucose (NG, squares) and high
glucose (HG, triangles) using SeaHorse. a shows better OCR in MSCs cultured in NG compared to MSCs cultured in HG, at day 7 of culture.
Additives marked with arrows, A: 1nM rPFO, B: 10 mM glutamate and malate +2uM FCCP (Complex-I substrate), c 10 mM succinate (Complex-II
substrate). b the experiment has been repeated with prior SOD2 upregulation in HG exposed cells, showing SOD2 upregulation did improve
mitochondrial respiration, compared to the panel on left
Fig. 7 Mitosox Red Dye to detect ROS in MSCs in HG at day-7 of culture: Using FACS Analyzer increased mitochondrial fluorescence was noted.
This increased fluorescence may be due to increased mitochondrial swelling, possibly secondary to ROS in high glucose state (red vs green). No
difference was noted at Day1 or Day4 exposure to HG. Blue- unstained cells in NG (negative control), Green- MSCs in normal glucose and Red-
MSCs in high glucose. ROS reactive oxygen species, MSCs mesenchymal stem cells, HG high glucose, FACS fluorescence activated cell sorting
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by AdSOD2 suggests the regulation of some aspects of
Complex I biogenesis by ROS signaling.
Figure 6a demonstrates that in HG exposed bone mar-
row derived MSCs Complex I-dependent respiration was
relatively less. The glutamate- plus malate-supported
respiration was significantly less in HG compared to NG
MSCs. However, the Complex II-dependent respiration
supported by succinate as substrate was also lower in
HG cells. Figure 6b shows that SOD2 up-regulation in
MSCs prior to HG exposure did improve mitochondrial
respiration, compared to the panel on left.
Figure 13 compares ADMSC respiration in the presence
of normal glucose and high glucose, following transduction
with adenovirus GFP (control-top panel), adenovirus SOD1
(middle panel) and adenovirus SOD2 (bottom panel) at day
10 of NG or HG culture. SOD2 transduced cells following
HG exposure actually improved respiration even more than
NG exposed cells. SOD1 also improved respiration but not
to the extent of SOD2 transduced cells.
In order to develop a therapeutic aspect to our find-
ings we decided to deliver SOD2 upregulated cells to
reduce inflammation and insulin resistance secondary to
Fig. 8 a (left panel) and b (right panel): Mitosox Red dye assay for detection and quantification of mitochondria generated reactive oxygen
species presence intra-cellularly: Post culture at day 7 in NG and HG. Left panel: ADMSCs plated in normal glucose (NG, 5.5 mM), Right panel:
ADMSCs plated in high glucose (HG, 25 mM). The fluorescence peaked at day 7 of culture and decayed beyond 14 days. Magnification: 10×.
c Showing relative MitoSox fluorescence of normal glucose vs high glucose exposed cells over two weeks. NG normal glucose, HG high glucose,
ADMSCs adipose tissue derived mesenchymal stem cells
Fig. 9 Mitotraker Green Dye Assay in NG and HG: NG (Left) and HG (right): Helps to visualize mitochondrial mass in HG, which unlike NG shows
fragmented fibrillary structures that are uniformly more fluorescent, at day 7 of culture; magnification: 20×. NG normal glucose, HG high glucose
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inflammation. When we delivered 1.5 million MSCs (trans-
duced with AdGFP) intraperitoneally, we demonstrated
using the appropriate staining method that an adequate
number of MSCs reached subcutaneous, omental and
epididymal fat pockets (Fig. 14a and 14b). We have also
verified by direct fluorescence that GFP upregulated MSCs
had reached the fat pockets. The “homing-in” of MSCs to
fat pockets is possibly secondary to inflammatory molecules
produced from fat pockets and can be detected as early as
one week post intraperitoneal (IP) delivery; however,.
assimilation is significantly better by the second week of IP
delivery, when MSCs may actually be coalescing with
fat pocket host cells (Fig. 14a, week 2 OM and week 2 EP).
Figure 14a shows GFP staining with DAB as secondary
staining agent for omental and epididymal fat. Figure 14b
demonstrates direct GFP staining for omental fat. The sec-
ondary staining method provided better clarity, confirming
GFP positive cells reaching fat depot and subsequently
assimilating in host tissue.
Next, we delivered hMSCs that were transduced prior to
delivery intraperitoneally (IP) with AdSOD2, in mice to
determine if over-expressing SOD2 in human MSCs can
reduce local inflammation and insulin resistance. After
“homing-in” these hMSCs possibly lie adjacent or assimilate
into native adipocytes, mimicking a co-culture scenario.
Five animals in each of three groups received IP admi-
nistration of the pre-determined number of hMSCs trans-
duced with: 1) AdGFP (control for adenoviral vector), 2)
Fig. 10 Mitosox Red Dye to detect ROS in MSCs in HG at Day-14 of culture, using FACS Analyzer: shows increased mitochondrial swelling, possibly
secondary to ROS in high glucose state (red vs green). Blue- SCM (negative control), green- MSCs in normal glucose and red- MSCs in High Glucose,
Orange: MSCs transduced with AdSOD2 and then exposed to high glucose. The figure on the right indicates that MSCs post SOD2 up-regulation
(orange) have less fluorescence than without (red line). In both cases the MSCs were HG exposed. ROS reactive oxygen species, MSCs mesenchymal
stem cells, FACS fluorescence activated cell sorting, SOD2 superoxide dismutase
Fig. 11 Gene expression of ADMSCs in high glucose, post transduction with Null or SOD2. ADMSC on culture for 14 days also showed reduction
in expression of both fat/adipogenic genes and also inflammatory genes (Fig. 11) when compared to Fig. 2. MSC mesenchymal stem cells, SOD2
superoxide dismutase. ADMSCs adipose tissue derived mesenchymal stem cells
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AdMnSOD suspended in 200 uL of PBS, and 3)
saline. hMSCs were transduced ex vivo and cultured
for five days before being delivered to db/db (Jackson
Labs) mice IP.
Outcome measures were glucose tolerance tests and body
weight and composition measurement. (Fig. 15a and 15b).
We demonstrated that transplantation of MnSOD up
regulated MSC improved glucose tolerance (Fig. 15a)
and total body weight and total fat mass in obese and
diabetic db/db mice compared to mice receiving eGFP
up-regulated MSCs, gradually reduced over the four
week observation period (Fig. 15b). There was no statis-
tically significant difference in body weight and body fat
mass between mice receiving GFP transduced MSCs and
saline over four weeks, post IP delivery of cells or saline.
Discussion
In this study we investigated the effect of glucose (HG vs
NG) on human subcutaneous adipose tissue derived-MSCs.
In the recent past we have investigated the effect of exercise
on diabetes and prediabetes patients using CD34+ progeni-
tor cells [23]. A significant percentage of diabetes patients
[24], particularly type 2, do present levels of 20-25 mM of
glucose (360 mg % to 450 mg %) and, therefore, discerning
the effect of high levels of glucose on undifferentiated multi-
potent mesenchymal stem cells is very important. It is also
important to discern the factors that influence MSCs differ-
entiation in a particular fashion and whether one can
manipulate gene expression ex-vivo so as to influence
differentiation.
From our series of experiments, we noted that HG accen-
tuates triacylglycerol accumulation in MSCs and this is as-
sociated with ROS presence particularly in mitochondria
which seems to peak at day 7 post HG exposure (Fig. 8).
The effect of ROS accumulation is also noted in reduced
oxygen consumption rate (OCR) of these cells at day 10,
which is accentuated at day 14. The reduced OCR seems
to be secondary to OxPhos Complex I deficiency. While
the lower expression of NDUFA1 mRNA and reduced
Complex I content suggest that Complex I assembly may
Fig. 12 Intracellular SOD assay: detection of SOD activity in SOD1
and SOD2 upregulated cells compared to AdNull transduced cells.
SOD superoxide dismutase. To ensure that superoxide dismutase
(SOD) has been truly upregulated intracellularly we assessed SOD
activity (Fig. 12) and demonstrated that SOD2 upregulated MSCs
have more dismutase activity and used less xanthine oxidase
compared to SOD1 upregulated cells indicating that SOD2
upregulated cells have more SOD activity than SOD1. Xanthine
oxidase (XO) is a key enzyme necessary to produce superoxide.
AdNull transduced cells were associated with maximum XO, as
expected, and thereby was associated with least SOD activity
Fig. 13 Comparison of ADMSC respiration in the presence of
normal glucose (NG-circles) and high glucose (HG-squares), following
transduction with GFP, SOD1 and SOD2 at day 10 of NG or HG
culture. ADMSC adipose tissue derived mesenchymal stem cells, GFP
green fluorescent protein, SOD superoxide dismutase
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be impaired in high glucose, a higher turnover of Complex
I cannot be excluded. No difference in Complex II content
but its activity points toward functional dysregulation of
Complex II. The correction of respiratory chain defi-
ciency by SOD2 suggests that oxidative stress impairs the
OXPHOS system in MSCs experiencing hyperglycemia.
Interestingly, the gene expression analysis showed that
up to day 7 of HG exposure there seems to be no major
difference between NG and HG exposed cells. However,
at day 14 the two principal genes that seem to be affected
are SOD2 and catalase both being anti-oxidants, of which
SOD2 is several fold upregulated. This phenomenon is
probably a cellular response to high glucose induced ROS.
Like others we, too, noted an upregulation of adipogenic
genes, such as FABP4 and PPARG, mature adipocyte
marker genes, such as perilipin, leptin and adiponectin,
and inflammatory genes, such as TNF alpha and IL6 [7].
Based on our finding from qPCR the critical genes
which the HG exposed cell tries to upregulate itself as
an attempt to self-preserve are anti-oxidants, particularly
SOD2 (mitochondrial SOD or MnSOD) (Fig. 2). There-
fore, to verify whether the effects induced by HG could
be reversible, we supplied the SOD2 ex-vivo, using
adenovirus-SOD2 by gene transfer. We decided to use
adenovirus, a DNA virus, in order to over-express a spe-
cific gene inside the MSC [25, 26].
Post SOD2 upregulation the detrimental effects of HG
on adipo-derived MSCs seem to be halted. The respira-
tory activity improved and Complex I dysfunction was
reversed. Post SOD2 upregulation HG exposed cells
demonstrate a reduction in adipogenic genes such
FABP4 and PPARG, mature adipocyte marker genes
such as perilipin, leptin and adiponectin and inflamma-
tory genes such TNF alpha and IL6.
We wanted to insure that the antioxidant upregulated
cells actually do have more superoxide dismutase and
did an assay to show there was more dismutase intra-
cellularly. Interestingly, SOD activity assay was more
Fig. 14 a GFP detection in fat depots at week 1 (upper panel) and week 2 (DAB secondary) with brown staining (lower panel). b GFP detection in
omental fat depots at week 1 and week 2 by direct laser confocal microscopy is also shown. GFP green fluorescent protein,DAB 3,3'-diaminobenzidine
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robust in SOD2 upregulated cells than SOD1 compared
to AdNull upregulated cells. SOD activity was also noted
in the conditioned media obtained from AdSOD1 and
AdSOD2 transduced cells unlike AdNull transduced
MSCs, indicating a beneficial paracrine property of the
anti-oxidant upregulated cells. Similarly, SOD1 trans-
duced cells showed better OCR than GFP transduced
cells but SOD2 transduced cells showed the best respir-
ation. Figures 4, 5 and 6 demonstrated that HG medi-
ated Complex I defect is not specific to site of origin for
the MSCs. In fact, both ADMSCs and BMMSCs demon-
strate a similar effect of poor respiration and Complex I
defect on exposure to HG beyond seven days.
To investigate therapeutic utility of genetically modi-
fied MSCs we delivered AdGFP upregulated adipo
derived-MSCs intraperitoneally. We used ADMSCs be-
cause we hoped to show coalescing of MSCs with the
host tissue and thereby deliver the gene and its paracrine
properties, better, to the surrounding inflamed adipose
tissues. We demonstrated that GFP up-regulated cells
do reach the distal fat pockets possibly chemo-attracted
by inflammatory cytokines being released from the fat
depots in the db/db leptin resistant mice. Indeed, the
most GFP positive cells (stained with GFP antibody and
DAB secondary) seem to be evident in the omental fat ra-
ther than any other fat depots, followed by subcutaneous
and epididymal fat. This finding is most probably due to
the route of cell delivery, which is intra-peritoneal.
When we delivered SOD2 upregulated cells and com-
pared with delivery of GFP upregulated cells we noted a
gradual decrease in fat mass (using Echo-MRI) in the
first group. At four weeks post-delivery of MSCs we per-
formed a glucose tolerance test (GTT) which clearly
showed improvement in GTT (n = 5) for the group that
received SOD2 upregulated MSCs. This is possibly
secondary to reduction in inflammation which re-
duced insulin resistance, fat mass and improved glu-
cose utilization. In this project we used the “homing”
property of the human MSCs which are known to
home to the site of inflammation and injury to deliver
anti-oxidant at a niche where ROS is produced. We
also utilized the non-immunogenic property of the
MSCs to deliver the cells in vivo in a mouse model of
diabetes and obesity. This technique can be utilized as
a novel and safe therapy in subjects suffering from
obesity and diabetes, utilizing their own subcutaneous
fat derived MSCs. Adenovirus used to up-regulate hu-
man antioxidants is a DNA virus and remains as an
episomal character with no integration with host gen-
ome. It is therefore safe for ex-vivo transduction and
gene upregulation before the virus free cell suspension
is delivered intraperitoneally. A limitation to this
process for human therapy in a chronic disease setting
of diabetes and obesity will be short term expression
of adenovirus mediated gene transfer, which would re-
quire multiple injections over a period of time. To
Fig. 15 a Glucose tolerance test in db / db mice 28 days after MSC delivery, intraperitoneally. b Weight of mice over four weeks that received
either GFP or SOD2 up-regulated MSCs. MSC mesenchymal stem cell, GFP green fluorescent protein, SOD2 superoxide dismutase 2
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avoid this issue, one can use adeno-associated virus
mediated gene transfer [23, 25] without causing long
term side-effects.
Conclusions
Hyperglycemia accentuates fat formation and adipo-
genesis in undifferentiated mesenchymal stem cells
which is associated with increased mitochondrial
superoxide accumulation, cellular inflammation and
impaired cellular respiration. The impaired cellular
oxygen consumption and Complex 1 dysfunction is not
specific to adipose derived MSCs but is also seen in
BMMSCs. When excess mitochondrial superoxide is
reduced using mitochondria specific SOD2 gene up-
regulation the hyperglycemia induced effects are abro-
gated including reduction of cellular inflammation. We
decided to investigate further if these genetically modi-
fied MSCs can be utilized in an obese diabetic mouse
model. We demonstrated that MSCs do home-in to in-
flamed adipocyte pockets and SOD2 upregulated cells
on delivery in diabetic obese mice do show reduction
in weight with improved glucose tolerance tests com-
pared to control. This finding can have significant im-
pact in diabetes therapeutics using human MSCs,
which could be obtained commercially or obtained
from diabetic subject’s fat depots.
Abbreviations
ADMSC: Adipose tissue derived mesenchymal stem cells; BMMSC: Bone
marrow derived mesenchymal stem cells; GTT: Glucose tolerance test
(intraperitoneal); HG: High glucose (25 mM); MSC: Mesenchymal stem cells;
NG: Normal glucose (5.5 mM); OCR: Oxygen consumption rate; ROS: Reactive
oxygen species; SOD: Superoxide dismutase enzyme.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
SS: conceived the study, designed and coordinated the experiments and
drafted the manuscript. CD: carried out the ADMSC respirometry and
RT-PCRs. CR: carried out Mitosox and Mitotraker experiments. CC: carried out
animal experiments and contributed to cellular experiments. CK: contributed
to western blot and BMMSC respirometry. NY: critically appraised the
manuscript, designed and interpreted ADMSC and BMMSC western blot and
BMMSC respirometry. All authors contributed to critical appraisal of the
manuscript and contributed to the methods section of different assays. All
authors read and approved the final manuscript.
Acknowledgements
We would like to thank Mary Young, MA, from Baystate Medical Center, and
Sara Houston from George Washington University, for their technical help.
Author details
1Department of Medicine, Division of Endocrinology and Metabolism, The
George Washington University, School of Medicine and Health Sciences,
2300 I Street, Ross Hall Suite: 450, Washington, DC 20037, USA. 2Pioneer
Valley Life Sciences Institute, and Division of Endocrinology, Diabetes &
Metabolism at Baystate Medical Center of Tufts University School of
Springfield, Springfield, MA, USA.
Received: 15 September 2015 Revised: 25 October 2015
Accepted: 4 November 2015
References
1. Kopelman PG. Obesity as a medical problem. Nature. 2000;404:635–43.
2. Couillard C, Mauriège P, Imbeault P, Prud'homme D, Nadeau A, Tremblay A,
et al. Hyperleptinemia is more closely associated with adipose cell
hypertrophy than with adipose tissue hyperplasia. Int J Obes Relat Metab
Disord. 2000;24:782–8.
3. Roncari DA. Hormonal influences on the replication and maturation of
adipocyte precursors. Int J Obes. 1981;5:547–52.
4. Spiegelman BM, Enerback S. The adipocyte: a multifunctional cell. Cell
Metab. 2006;4:425–7.
5. García-Castro J, Trigueros C, Madrenas J, Pérez-Simón JA, Rodriguez R,
Menendez P. Mesenchymal stem cells and their use as cell
replacement therapy and disease modelling tool. J Cell Mol Med.
2008;12(6B):2552–65.
6. Dhanasekaran M, Indumathi S, Rajkumar JS, Sudarsanam D. Effect of high
glucose on extensive culturing of mesenchymal stem cells derived from
subcutaneous fat, omentum fat and bone marrow. Cell Biochem Funct.
2013;31(1):20–9.
7. Aguiari P, Leo S, Zavan B, Vindigni V, Rimessi A, Bianchi K, et al. High
glucose induces adipogenic differentiation of muscle-derived stem cells.
Proc Natl Acad Sci U S A. 2008;105(4):1226–31.
8. Li YM, Schilling T, Benisch P, Zeck S, Meissner-Weigl J, Schneider D,
et al. Effects of high glucose on mesenchymal stem cell
proliferation and differentiation. Biochem Biophys Res Commun.
2007;363(1):209–15.
9. Montague CT, O'Rahilly S. The perils of portliness: causes and consequences
of visceral adiposity. Diabetes. 2000;49:883–8.
10. Allen RG, Tresini M. Oxidative stress and gene regulation. Free Radic Biol
Med. 2000;28:463–99.
11. Valko M et al. Free radicals and antioxidants in normal physiological
functions and human disease. Int J Biochem Cell Biol. 2007;39:44–84.
12. Cadenas E, Davies KJ. Mitochondrial free radical generation, oxidative stress,
and aging. Free Radic Biol Med. 2000;29:222–30.
13. Balaban RS, Nemoto S, Finkel T. Mitochondria, oxidants, and aging. Cell.
2005;120:483–95.
14. Keaney Jr JF et al. Obesity and systemic oxidative stress: clinical
correlates of oxidative stress in the Framingham Study. Arterioscler
Thromb Vasc Biol. 2003;23:434–9.
15. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, et al.
Increased oxidative stress in obesity and its impact on metabolic syndrome.
J Clin Invest. 2004;114:1752–61.
16. Temple NJ, Gladwin KK. Fruit, vegetables, and the prevention of cancer:
research challenges. Nutrition. 2003;19:467–70.
17. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T,
Kaneda Y, et al. Normalizing mitochondrial superoxide production
blocks three pathways of hyperglycaemic damage. Nature.
2000;404:787–90.
18. Yadava N, Houchens T, Potluri P, Scheffler IE. Development and
characterization of a conditional mitochondrial complex I assembly system.
J Biol Chem. 2004;279(13):12406–13.
19. Yadava N, Potluri P, Smith EN, Bisevac A, Scheffler IE. Species-specific
and mutant MWFE proteins. Their effect on the assembly of a
functional mammalian mitochondrial complex I. J Biol Chem. 2002;
277(24):21221–30.
20. Kim C, Patel P, Gouvin LM, Brown ML, Khalil A, Henchey EM, et al.
Comparative analysis of the mitochondrial physiology of pancreatic β cells.
Bioenergetics. 2014;3(1):110.
21. Chinta SJ, Rane A, Yadava N, Andersen JK, Nicholls DG,
Polster BM. Reactive oxygen species regulation by AIF- and
complex I-depleted brain mitochondria. Free Radic Biol Med. 2009;
46(7):939–47.
22. Kovner I, Taicher GZ, Mitchell AD. Calibration and validation of EchoMRI™
whole body composition analysis based on chemical analysis of
piglets, in comparison with the same for DXA. Int J Body Compos Res.
2010;8(1):17–29.
23. Sen S, Witkowski S, Lagoy A, Islam AM. A six-week home exercise program
improves endothelial function and CD34+ circulating progenitor cells in
patients with pre-diabetes. J Endocrinol Metab. 2015;5(1–2):163–71.
http://www.jofem.org/index.php/jofem/article/view/273/323.
24. Standards of medical care in diabetes-2014; American Diabetes Association.
Diabetes Care. 2014; 37:S14–S80.
Sen et al. Stem Cell Research & Therapy  (2015) 6:242 Page 13 of 14
25. Sen S, Conroy S, Hynes SO, McMahon J, O'Doherty A, Bartlett JS, et al. Gene
delivery to the vasculature mediated by low-titre adeno-associated virus
serotypes 1 and 5. J Gene Med. 2008;10(2):143–51.
26. Sen S, Merchan J, Dean J, Ii M, Gavin M, Silver M, et al. Autologous
transplantation of endothelial progenitor cells genetically modified by
adeno-associated viral vector delivering IGF-1 gene following myocardial
infarction. Hum Gene Ther. 2010;21:1327–34.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Sen et al. Stem Cell Research & Therapy  (2015) 6:242 Page 14 of 14
